ALX Oncology Reports Positive Interim Phase 2 Data From ASPEN-06 Trial Of Evorpacept For Cancer

RTTNews | hace 584
Stocktwits
ALX Oncology Reports Positive Interim Phase 2 Data From ASPEN-06 Trial Of Evorpacept For Cancer

(RTTNews) - Immuno-oncology company ALX Oncology Holdings Inc. (ALXO) announced Tuesday positive prespecified interim Phase 2 data from its ASPEN-06 clinical trial, a randomized multi-center international study evaluating evorpacept, the Company's CD47 blocking therapeutic, in combination with trastuzumab, CYRAMZA (ramucirumab) and paclitaxel for the treatment of patients with HER2-positive gastric/gastroesophageal junction (GEJ) cancer.

Evorpacept is the first CD47 blocker to show activity in a global randomized study in solid tumors.

The interim efficacy results showed the confirmed overall response rate for evorpacept combination treatment was 52% compared to 22% for control treatment.

This prespecified interim analysis represents results from 54 randomized patients with second and third line gastric/GEJ cancer, including a meaningful number of patients previously treated with ENHERTU (trastuzumab deruxtecan) and checkpoint inhibitors.

Patients were treated with evorpacept at 30 mg/kg every two weeks, mirroring the treatment cycle of trastuzumab, CYRAMZA and paclitaxel.

Tags: ALXO
Stocktwits
read more
Bay Street Headed For Positive Start

Bay Street Headed For Positive Start

Firm commodity prices and steady global stocks amid optimism about trade deals point to a positive start for the Canadian market on Friday. Canadian jobs data for the month of April, and corporate earnings updates are also set to make an impact.
RTTNews | hace 3h 4min
FTSE Up Nearly 0.5% On Easing Tariff Concerns

FTSE Up Nearly 0.5% On Easing Tariff Concerns

U.K. stocks are up on Friday, supported by some strong earnings updates, and continued optimism about trade deals. U.S. President Donald Trump said on Thursday that the meetings with China on trade and economic issues could be "very substantive" and lead to tariff reductions.
RTTNews | hace 4h 46min
CAC 40 Up 0.75% On Easing Trade Tensions

CAC 40 Up 0.75% On Easing Trade Tensions

French stocks are exhibiting strength on Friday, buoyed by news about the U.S. and U.K. agreeing on a trade deal, and the upcoming U.S. - China trade talks this weekend.
RTTNews | hace 5h 21min
Sensex, Nifty Extend Losses As Operation Sindoor Continues

Sensex, Nifty Extend Losses As Operation Sindoor Continues

Indian shares fell sharply on Friday to extend losses from the previous session after the Indian Army said it had countered the Pakistani attack on Indian cities late last night, fueling concerns of further escalation between the two nuclear-armed nations.
RTTNews | hace 5h 29min
Yamaha Recalls 34K Power Adaptors For Pianos, Workstations

Yamaha Recalls 34K Power Adaptors For Pianos, Workstations

Yamaha Corp. of America, affiliated to Japan's Yamaha Corp., is recalling about 37,400 units of power adaptors for digital pianos and music workstations citing risk of burn and fire, according to the U.S. Consumer Product Safety Commission. The recall involves Yamaha-brand AC adaptors with model number PA-300C that were sold with Yamaha-brand arranger workstations, digital pianos...
RTTNews | hace 6h 21min
Herramientas
Calendario económico
Market Hours
Interest Rates
Holidays Calendar
Mercados Forex
Volatilidad Forex
Correlación Forex
Noticias del Forex
forex analysis
Datos COT
Liquidez
Calculadoras Forex
Heat Map del Forex
Indicators Heatmap
Comunidad
Comunidad
Sistemas
Sistemas más populares
Estrategias
Concursos
Gráficos Forex
Sentimiento Forex
Indicador de perspectivas
Revisiones
Corredores de bolsa
Prop Trading Firms
Servicios SPV
Proveedor de señales
Servicios de programación de AE
Affiliate Programs
Servicios de corretaje PAMM
Servicios de programas de rebaja
Plataformas de trading
Asesores Expertos
Exchanges de Criptomonedas
Trading Courses
Corredores de bolsa
Spreads de Forex
Cotizaciones de los corredores de Forex
Swaps de corredores de Forex
Volumen del corredor Forex
Promociones de corredores Forex Press Release
Plataforma
Widgets
Funciones
API
RSS
Stock Portfolio
Affiliate Software
Gráficos avanzados
Soporte
FAQ
Ayuda
Póngase en contacto con nosotros
¡Informar de un error!
Acerca de
Blog
© 2025 Myfxbook Ltd. Todos los Derechos Reservados.
ADVERTENCIA DE ALTO RIESGO: El comercio de divisas implica un alto nivel de riesgo que puede no ser adecuado para todos los inversores. El efecto de apalancamiento crea un riesgo adicional y una exposición a las pérdidas. Antes de decidirse a operar con divisas, considere cuidadosamente sus objetivos de inversión, su nivel de experiencia y su tolerancia al riesgo. Podría perder una parte o la totalidad de su inversión inicial. No invierta dinero que no puede permitirse perder. Infórmese sobre los riesgos asociados al trading de divisas y pida consejo a un asesor financiero o fiscal independiente si tiene alguna duda. Todos los datos y la información se proporcionan "tal cual" con fines informativos únicamente y no están destinados a fines comerciales o de recomendación. Los resultados pasados no son indicativos de los resultados futuros.